• Skip to primary navigation
  • Skip to main content
  • Skip to primary navigation
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Winthrop P. Rockefeller Cancer Institute: Research
  • UAMS Health
  • Jobs
  • Giving
  • About
  • Resources
    • Clinical Trials Office
    • Internal Funding Opportunities
    • Research Training and Education
    • Research Calendar
    • Shared Resources
    • Cancer Clinical Research Pre-Review Approval Process
  • Membership
  • Research Activity
    • Research Programs
    • Clinical Research
    • Public Health Studies
  1. University of Arkansas for Medical Sciences
  2. Winthrop P. Rockefeller Cancer Institute
  3. Research
  4. Our Research
  5. Research Programs
  6. Cancer Prevention and Population Sciences

Cancer Prevention and Population Sciences

This Program Addresses Entire Cancer Continuum

The Cancer Prevention & Population Science (CPPS) program at the UAMS Winthrop P. Rockefeller Cancer Institute conducts research to define etiologic factors underlying health disparities in the urban-rural continuum.

Learn More

Cancer Prevention and Population Sciences Members

View all the members in Cancer Prevention and Population Sciences Program

View Members

Mission Statement

The main mission of this program is to address cancer health disparity in Arkansas. The overall cancer incidences of Arkansans are similar to those of the population of the United States at large.  However, cancer mortality rates are higher among Arkansans.  Documented lower screening rates for breast, cervical, and colon cancers likely explain such disparity at least partially.  Access and quality of care after cancer diagnosis may also be a contributing factor given the largely rural nature of the state.  The cancer types with most significant health care disparities in Arkansas have been identified, but are not limited to, breast, cervical, colon, lung, and prostate.

Our Approach

Our approach is team-oriented and translationally based that covers the entire cancer continuum — primary prevention, early detection, laboratory research, clinical trials and applications, diagnosis and treatment, quality of life, and survivorship.

Our research activities include evaluating primary and secondary prevention measures, understanding molecular factors associated with the development and optimal management of cancer, and assessing community-based strategies to improve cancer outcomes.

Research in the CPPS program is organized according to our social ecological model that progresses from discovery to intervention to dissemination.

Primary Areas of Research

Reduce cancer incidence and progression

Reduce Cancer Incidence and Progression

Done by identifying etiology and risk factors, as well as developing and implementing novel strategies/interventions to reduce cancer risk and improve cancer outcomes.

Mammovan

Decrease Regional Cancer Disparities

Done through developing and testing implementation methods of evidence-based dissemination strategies designed to promote cancer prevention and early detection.

Immune System

Understand the Role of Immune System in Cancer Development

Also develop and test immune-mediated interventions for preventing cancers and recurrence of cancers, as well as reducing progression of cancers in a watchful waiting state.

Featured Publications

  • Crown A, Berry C, Khabele D, Fayanju OM, Cobb A, Backhus L, et al. The Role of Race and Gender in the Career Experiences of Black/African-American Academic Surgeons: A Survey of the Society of Black Academic Surgeons and a Call to Action. Annals of surgery. 2020;(): .
  • Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, et al. Shared heritability and functional enrichment across six solid cancers. Nature communications. 2019;10(1): 431. PMC6347624.
  • Ramakrishnan S, Steck SE, Arab L, Zhang H, Bensen JT, Fontham ETH, Johnson CS, Mohler JL, Smith GJ, Su LJ, Woloszynska A. Association among plasma 1,25(OH)2D, ratio of 1,25(OH)2D to 25(OH)D, and prostate cancer aggressiveness. The Prostate. 2019;79(10): 1117-1124. PMC6593756.
  • Ramos JC, Sparano JA, Chadburn A, Reid EG, Ambinder RF, Siegel ER, et al. Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial). Blood. 2020;136(11): 1284-1297. PMC7483436.
  • Shibata T, Lieblong BJ, Sasagawa T, Nakagawa M. The promise of combining cancer vaccine and checkpoint blockade for treating HPV-related cancer. Cancer treatment reviews. 2019;78(): 8-16. PMC6710123.
  • Taylor SE, Chu T, Elvin JA, Edwards RP, Zorn KK. Phase II study of everolimus and bevacizumab in recurrent ovarian, peritoneal, and fallopian tube cancer. Gynecologic oncology. 2019.

Meeting Time

The Cancer Prevention and Population Sciences Program meeting times vary. Please contact Ariel Washington awashington3@uams.edu

Program Leader

The title of our program describes its focus, which is cancer prevention on the population level.

For more information about the Cancer Prevention and Population Services Research Program, contact Ariel Washington awashington3@uams.edu..

Mayumi Nakagawa, M.D., Ph.D. Bio

Subpages

  • Colorectal Cancer Screenings
  • Cervical Cancer Education and Prevention
Winthrop P. Rockefeller Cancer Institute LogoWinthrop P. Rockefeller Cancer InstituteWinthrop P. Rockefeller Cancer Institute
Address: 449 Jack Stephens Dr., Little Rock, AR 72205
Parking Deck: 4018 W Capitol Ave, Little Rock, AR 72205
Appointments: (501) 296-1200
Referring Physicians: (501) 686-6080
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy

© 2023 University of Arkansas for Medical Sciences